Table 3 Lipid and hormone plasma levels in MI-resistant patients at baseline and after MI plus α-LA treatment
From: Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
Plasma levels of: | Baseline | End of treatment | p |
|---|---|---|---|
Total cholesterol (mg/dl) | 211 ± 22 | 190 ± 26 | ≤ 0.05 |
HDL (mg/dl) | 35 ± 8 | 37 ± 6 | n.s. |
LDL (mg/dl) | 128 ± 21 | 127 ± 20 | n.s. |
Triglycerides (mg/dl) | 186 ± 51 | 119 ± 38 | ≤ 0.05 |
Progesterone (ng/ml) | 0.7 ± 0.3 | 0.6 ± 0.1 | n.s. |
Testosterone (ng/dl) | 88 ± 38 | 57 ± 31 | ≤ 0.05 |
Free testosterone (ng/dl) | 1.3 ± 0.5 | 0.6 ± 0.3 | < 0.001 |
Androstenedione (ng/dl) | 198 ± 59 | 165 ± 47 | n.s. |
17β-estradiol (ng/dl) | 9.1 ± 3.7 | 9.2 ± 3.9 | n.s. |
Dehydroepiandrosterone sulfate (μg/dl) | 530 ± 231 | 279 ± 87 | < 0.01 |
SHBG (μg/dl) | 2.6 ± 0.9 | 5.0 ± 2.1 | < 0.001 |